Medical research and development DHA sbir phase II contract, proposal no. H2-0647, titled, "genecapture's fieldable diagnostic platform for rapid ID and AST of wound pathogens"
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0101
- Awardee
-
Genecapture, Inc. UEI LVKCTP3NJ1K1
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $1,099,957
Award facts
- Opportunity
-
- HQ003421R1DSB Solicitation number
- Contract value 100% obligated
- $1,099,956.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Huntsville, AL 35806, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
About this award
Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under a firm fixed price arrangement. The contract has a total small business set aside designation. The SBIR program aims to support innovative research with commercial potential from small businesses to meet U.S. Army medical needs. This award will allow Genecapture to further develop its diagnostic platform for rapidly identifying and testing antibiotic susceptibility of pathogens found in wounds, advancing the Army's goals in treating injured soldiers.
Quick answers
Who was awarded contract W81XWH21C0101?
W81XWH21C0101 was awarded to Genecapture, Inc. by Medical Command (Department of the Army) on September 3, 2021.
How much is contract W81XWH21C0101 worth?
The government has obligated $1,099,957 on W81XWH21C0101.
Was contract W81XWH21C0101 competed?
The extent of competition for W81XWH21C0101 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award